In the manuscript by Pires et al., the role of proteins whose function is known to be altered in basal-like breast cancer cells were investigated in an immortal though not tumorigenic mammary tumor cell line, MCF10A.[@R6] MCF10A is particularly useful for the present studies as based on expression profiling studies it expresses markers most often associated with the basal-epithelial phenotype.[@R7] The authors chose to examine three well described proteins whose functions are altered in basal breast cancer cells; PTEN deletion; p53 mutant inactive; EGFR (also called ERBB1) mutant active. As individual oncogenes, only deletion of PTEN could stimulate 2-dimensional MCF10A cell growth in the absence of exogenous growth factors; and, the effect of a single PTEN deletion was not replicated when cells were grown in a 3-dimensional culture in soft agar. Interestingly, expression of H-RAS V12 in MCF10A cells did facilitate 3D culture growth; as the H-RAS V12 point mutants specific for activation of ERK/AKT/RAL were not used in this study it is not known which specific downstream pathways are required for this 3D growth effect.[@R8]^,^[@R9] The authors then performed analyses using double and triple mutant MCF10A cells. In 2D culture all double mutants except the EGFR + p53 mutant grew robustly. Similar data were obtained when these cells were grown in 3D culture. Of note was that the triple mutant (p53 + PTEN + EGFR) grew more rapidly and formed more colonies than either of the matched double mutants. This supports the multi-hit hypothesis in the MCF10A line. Nevertheless, the triple modified cells were unable to form tumors in SCID mice after 3 mo, suggesting that still more mutations are required for in vivo growth. Whether the H-RAS V12 MCF10A cells used in these studies formed tumors was not reported.

A notable difference in signaling between (PTEN + p53) cells and cells expressing the EGFR was further activation of AKT, though this activation of AKT could not explain why (p53 + PTEN + EGFR) grew more rapidly and formed more colonies. A more significant difference was that (p53 + PTEN + EGFR) cells expressed higher protein levels of EGFR and had higher phospho-EGFR levels. Whether (p53 + PTEN + EGFR) cells also express more paracrine EGFR ligands, e.g., TGFα; HB-EGF, was not reported. Collectively the data in the Pires et al. study argue that multiple pathways downstream and upstream of RAS are required to fully transform the basal-cell like cell line MCF10A.
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